Savara SVRA
NASDAQ SVRA
$4.81 -0.24 (-4.75%)
At close: Oct 2, 2026 · 4:00 PM EDT

Savara (SVRA) Selling, General & Administrative (2010 - 2026)

Updated

Savara's Selling, General & Administrative was $18.99 million in Q2 2026, up 78.2% from $10.66 million a year earlier and up 22.0% from the prior quarter.

Analysis

Savara (SVRA) Selling, General & Administrative (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, Savara's Selling, General & Administrative was $56.71 million through Jun 30, 2026, up 68.0% year-over-year; for FY2025, it came in at $42.06 million, up 68.0% from FY2024.

  • Selling, General & Administrative has now increased for three consecutive years, with a five-year compound annual growth rate of 24.1% (FY2020 to FY2025).
  • In earlier years, Selling, General & Administrative was $25.04 million in FY2024 (+59.8%), $15.67 million in FY2023 (+43.4%), $10.93 million in FY2022 (-11.5%) and $12.35 million in FY2021 (-13.4%).
  • The Q2 2026 figure marks the highest quarterly Selling, General & Administrative in data going back to Q2 2010.
  • Compared with a year earlier, Selling, General & Administrative has increased for 15 straight quarters, with growth averaging 66.2% over the last eight quarters.
  • The best year-over-year quarter for Selling, General & Administrative over five years was Q2 2025 (growth of 92.3%); the worst was Q3 2021 (a decline of 36.7%).
  • Per Business Quant data, SVRA's Selling, General & Administrative in the three quarters before Q2 2026 was $15.57 million (Q1 2026), $12.53 million (Q4 2025) and $9.63 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Savara 987.97 Mn 987.97 Mn - 18.99 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 18.99 Mn
Mar 31, 2026 15.57 Mn
Dec 31, 2025 12.53 Mn
Sep 30, 2025 9.63 Mn
Jun 30, 2025 10.66 Mn
Mar 31, 2025 9.25 Mn
Dec 31, 2024 7.85 Mn
Sep 30, 2024 6.01 Mn
Jun 30, 2024 5.54 Mn
Mar 31, 2024 5.64 Mn
Dec 31, 2023 4.85 Mn
Sep 30, 2023 4.15 Mn
Jun 30, 2023 3.30 Mn
Mar 31, 2023 3.37 Mn
Dec 31, 2022 3.24 Mn
Sep 30, 2022 2.38 Mn
Jun 30, 2022 2.96 Mn
Mar 31, 2022 2.35 Mn
Dec 31, 2021 3.02 Mn
Sep 30, 2021 3.40 Mn
API Access

Savara Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=SVRA&period=max&api_key=YOUR_API_KEY